Detection of liver metastases in patients with adenocarcinomas of the gastrointestinal tract: comparison of 18F-FDG PET/CT and MR imaging

Abdominal Imaging

Volumn 40, Issue 5, 2015, Pages 1213-1222

  Maegerlein, Christian ^a   Fingerle, Alexander A ^a   Souvatzoglou, Michael ^a   Rummeny, Ernst J ^a   Holzapfel, Konstantin ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

18F FDG PET CT; Adenocarcinomas of the gastrointestinal tract; Diffusion weighted MR imaging (DWI); Liver metastases; Magnetic resonance imaging

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GADOLINIUM PENTETATE MEGLUMINE; IOMEPROL; MEGLUMINE IOXITALAMATE; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DIFFUSION WEIGHTED IMAGING; FEMALE; FOLLOW UP; GASTROINTESTINAL CARCINOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; INTERMETHOD COMPARISON; LIVER METASTASIS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PET-CT SCANNER; PRIORITY JOURNAL; RADIOLOGIST; SENSITIVITY AND SPECIFICITY; TUMOR VOLUME; ADENOCARCINOMA; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; GASTROINTESTINAL TUMOR; LIVER NEOPLASMS; MIDDLE AGED; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; RETROSPECTIVE STUDY; SECONDARY; VERY ELDERLY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; FEMALE; FLUORODEOXYGLUCOSE F18; GASTROINTESTINAL NEOPLASMS; HUMANS; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84930180365     PISSN: 09428925     EISSN: 14320509     Source Type: Journal    
DOI: 10.1007/s00261-014-0283-x     Document Type: Article

References (38)

1. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, et al. (2013) Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 49(6):1374–1403. doi:10.1016/j.ejca.2012.12.027
2. Hess KR, Varadhachary GR, Taylor SH, et al. (2006) Metastatic patterns in adenocarcinoma. Cancer 106(7):1624–1633. doi:10.1002/cncr.21778
3. Manfredi S, Lepage C, Hatem C, et al. (2006) Epidemiology and management of liver metastases from colorectal cancer. Ann Surg 244(2):254–259. doi:10.1097/01.sla.0000217629.94941.cf
4. Zhang S, Gao F, Luo J, Yang J (2010) Prognostic factors in survival of colorectal cancer patients with synchronous liver metastasis. Colorectal Dis 12(8):754–761. doi:10.1111/j.1463-1318.2009.01911.x
5. Feliberti EC, Wagman LD (2006) Radiofrequency ablation of liver metastases from colorectal carcinoma. Cancer Control 13(1):48–51
6. Liapi E, Geschwind JF (2007) Transcatheter and ablative therapeutic approaches for solid malignancies. J Clin Oncol 25(8):978–986. doi:10.1200/JCO.2006.09.8657
7. Van de Wiele C, Maes A, Brugman E, et al. (2012) SIRT of liver metastases: physiological and pathophysiological considerations. Eur J Nucl Med Mol Imaging 39(10):1646–1655. doi:10.1007/s00259-012-2189-6
8. Yamane B, Weber S (2009) Liver-directed treatment modalities for primary and secondary hepatic tumors. Surg Clin North Am 89(1):97–113 (ix). doi:10.1016/j.suc.2008.10.004
9. Gallinger S, Biagi JJ, Fletcher GG, et al. (2013) Liver resection for colorectal cancer metastases. Curr Oncol 20(3):e255–e265. doi:10.3747/co.20.1341
10. Vigano L, Russolillo N, Ferrero A, et al. (2012) Evolution of long-term outcome of liver resection for colorectal metastases: analysis of actual 5-year survival rates over two decades. Ann Surg Oncol 19(6):2035–2044. doi:10.1245/s10434-011-2186-1
11. Larsen LP, Rosenkilde M, Christensen H, et al. (2009) Can contrast-enhanced ultrasonography replace multidetector-computed tomography in the detection of liver metastases from colorectal cancer? Eur J Radiol 69(2):308–313. doi:10.1016/j.ejrad.2007.10.023
12. Muhi A, Ichikawa T, Motosugi U, et al. (2010) Diagnosis of colorectal hepatic metastases: contrast-enhanced ultrasonography versus contrast-enhanced computed tomography versus superparamagnetic iron oxide-enhanced magnetic resonance imaging with diffusion-weighted imaging. J Magn Reson Imaging 32(5):1132–1140. doi:10.1002/jmri.22360
13. Bipat S, van Leeuwen MS, Comans EF, et al. (2005) Colorectal liver metastases: CT, MR imaging, and PET for diagnosis—meta-analysis. Radiology 237(1):123–131. doi:10.1148/radiol.2371042060
14. Titu LV, Breen DJ, Nicholson AA, Hartley J, Monson JR (2006) Is routine magnetic resonance imaging justified for the early detection of resectable liver metastases from colorectal cancer? Dis Colon Rectum 49(6):810–815. doi:10.1007/s10350-006-0537-y
15. Rappeport ED, Loft A, Berthelsen AK, et al. (2007) Contrast-enhanced FDG-PET/CT vs. SPIO-enhanced MRI vs. FDG-PET vs. CT in patients with liver metastases from colorectal cancer: a prospective study with intraoperative confirmation. Acta Radiol 48(4):369–378. doi:10.1080/02841850701294560
16. Koh DM, Brown G, Riddell AM, et al. (2008) Detection of colorectal hepatic metastases using MnDPDP MR imaging and diffusion-weighted imaging (DWI) alone and in combination. Eur Radiol 18(5):903–910. doi:10.1007/s00330-007-0847-z
17. Floriani I, Torri V, Rulli E, et al. (2010) Performance of imaging modalities in diagnosis of liver metastases from colorectal cancer: a systematic review and meta-analysis. J Magn Reson Imaging 31(1):19–31. doi:10.1002/jmri.22010
18. Yong TW, Yuan ZZ, Jun Z, et al. (2011) Sensitivity of PET/MR images in liver metastases from colorectal carcinoma. Hell J Nucl Med 14(3):264–268
19. Eiber M, Fingerle AA, Brugel M, et al. (2012) Detection and classification of focal liver lesions in patients with colorectal cancer: retrospective comparison of diffusion-weighted MR imaging and multi-slice CT. Eur J Radiol 81(4):683–691. doi:10.1016/j.ejrad.2011.01.072
20. Niekel MC, Bipat S, Stoker J (2010) Diagnostic imaging of colorectal liver metastases with CT, MR imaging, FDG PET, and/or FDG PET/CT: a meta-analysis of prospective studies including patients who have not previously undergone treatment. Radiology 257(3):674–684. doi:10.1148/radiol.10100729
21. Semelka RC, Martin DR, Balci C, Lance T (2001) Focal liver lesions: comparison of dual-phase CT and multisequence multiplanar MR imaging including dynamic gadolinium enhancement. J Magn Reson Imaging 13(3):397–401
22. Holzapfel K, Reiser-Erkan C, Fingerle AA, et al. (2011) Comparison of diffusion-weighted MR imaging and multidetector-row CT in the detection of liver metastases in patients operated for pancreatic cancer. Abdom Imaging 36(2):179–184. doi:10.1007/s00261-010-9633-5
23. Rosa F, Meimarakis G, Stahl A, et al. (2004) Colorectal cancer patients before resection of hepatic metastases. Impact of (18)F-FDG PET on detecting extrahepatic disease. Nuklearmedizin. Nucl Med 43(4):135–140. doi:10.1267/NUKL04040135
24. Kong G, Jackson C, Koh DM, et al. (2008) The use of 18F-FDG PET/CT in colorectal liver metastases—comparison with CT and liver MRI. Eur J Nucl Med Mol Imaging 35(7):1323–1329. doi:10.1007/s00259-008-0743-z
25. Seo HJ, Kim MJ, Lee JD, Chung WS, Kim YE (2011) Gadoxetate disodium-enhanced magnetic resonance imaging versus contrast-enhanced 18F-fluorodeoxyglucose positron emission tomography/computed tomography for the detection of colorectal liver metastases. Invest Radiol 46(9):548–555. doi:10.1097/RLI.0b013e31821a2163
26. Bartolozzi C, Cioni D, Donati F, Lencioni R (2001) Focal liver lesions: MR imaging-pathologic correlation. Eur Radiol 11(8):1374–1388
27. Horton KM, Bluemke DA, Hruban RH, Soyer P, Fishman EK (1999) CT and MR imaging of benign hepatic and biliary tumors. Radiographics 19(2):431–451
28. Semelka RC, Brown ED, Ascher SM, et al. (1994) Hepatic hemangiomas: a multi-institutional study of appearance on T2-weighted and serial gadolinium-enhanced gradient-echo MR images. Radiology 192(2):401–406
29. Couinaud C (1954) Lobes et segments hepatiques: notes sur l’architecture anatomiques et chirurgicale du foie. Presse Med 62(33):709–712
30. Cohen J (1968) Weighted kappa: nominal scale agreement with provision for scaled disagreement or partial credit. Psychol Bull 70(4):213–220
31. Coenegrachts K, De Geeter F, ter Beek L, et al. (2009) Comparison of MRI (including SS SE-EPI and SPIO-enhanced MRI) and FDG-PET/CT for the detection of colorectal liver metastases. Eur Radiol 19(2):370–379. doi:10.1007/s00330-008-1163-y
32. Liau KH, Blumgart LH, DeMatteo RP (2004) Segment-oriented approach to liver resection. Surg Clin North Am 84(2):543–561. doi:10.1016/j.suc.2003.12.003
33. Khalaf M, Abdel-Nabi H, Baker J, et al. (2008) Relation between nodule size and 18F-FDG-PET SUV for malignant and benign pulmonary nodules. J Hematol Oncol 1:13. doi:10.1186/1756-8722-1-13
34. Badiee S, Franc BL, Webb EM, et al. (2008) Role of IV iodinated contrast material in 18F-FDG PET/CT of liver metastases. Am J Roentgenol 191(5):1436–1439. doi:10.2214/AJR.07.3750
35. Holzapfel K, Eiber MJ, Fingerle AA, et al. (2012) Detection, classification, and characterization of focal liver lesions: value of diffusion-weighted MR imaging, gadoxetic acid-enhanced MR imaging and the combination of both methods. Abdom Imaging 37(1):74–82. doi:10.1007/s00261-011-9758-1
36. Ruers TJ, Wiering B, van der Sijp JR, et al. (2009) Improved selection of patients for hepatic surgery of colorectal liver metastases with (18)F-FDG PET: a randomized study. J Nucl Med 50(7):1036–1041. doi:10.2967/jnumed.109.063040
37. Wiering B, Adang EM, van der Sijp JR, et al. (2010) Added value of positron emission tomography imaging in the surgical treatment of colorectal liver metastases. Nucl Med Commun 31(11):938–944. doi:10.1097/MNM.0b013e32833fa9ba
38. Plathow C, Weber WA (2008) Tumor cell metabolism imaging. J Nucl Med 49(Suppl 2):43S–63S. doi:10.2967/jnumed.107.045930